MARKET

ALMS

ALMS

Alumis Inc
NASDAQ
24.41
-1.14
-4.46%
After Hours: 24.35 -0.06 -0.25% 19:34 08/13 EDT
OPEN
25.59
PREV CLOSE
25.55
HIGH
25.86
LOW
24.06
VOLUME
832.44K
TURNOVER
--
52 WEEK HIGH
31.35
52 WEEK LOW
3.760
MARKET CAP
3.11B
P/E (TTM)
-12.7043
1D
5D
1M
3M
1Y
5Y
1D
Alumis reports Q2 results
Seeking Alpha · 3h ago
*Alumis 2Q Loss $142.2M >ALMS
Dow Jones · 3h ago
*Alumis: Runway Expected Into 4Q27 >ALMS
Dow Jones · 3h ago
*Alumis 2Q Rev $1.7M >ALMS
Dow Jones · 3h ago
Press Release: Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements
Dow Jones · 3h ago
Alumis Inc. (ALMS) Receives a Rating Update from a Top Analyst
TipRanks · 8h ago
Alumis Psoriasis Treatment Shows Leading Skin Clearance Rates
Benzinga · 2d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: ProKidney (PROK), Crinetics Pharmaceuticals (CRNX) and Alumis Inc. (ALMS)
TipRanks · 2d ago
More
About ALMS
Alumis Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing next-generation targeted therapies with the potential to significantly improve patient health and outcomes across a range of immune-mediated diseases. Leveraging its proprietary data analytics platform and precision approach, the Company is developing a pipeline of oral tyrosine kinase 2 (TYK2) inhibitors, consisting of envudeucitinib for the treatment of systemic immune-mediated disorders, such as moderate-to-severe plaque psoriasis and systemic lupus erythematosus, and A-005 for the treatment of neuroinflammatory and neurodegenerative diseases. In addition, its pipeline also includes lonigutamab, a subcutaneously delivered anti-insulin-like growth factor 1 receptor therapy for the treatment of thyroid eye disease, as well as several preclinical programs identified through this precision approach.

Webull offers Alumis Inc stock information, including NASDAQ: ALMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALMS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALMS stock methods without spending real money on the virtual paper trading platform.